News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Jean-Charles Soria: The oncology dealmaking landscape is shifting
Jean-Charles Soria/LinkedIn
Mar 8, 2025, 02:12

Jean-Charles Soria: The oncology dealmaking landscape is shifting

Jean-Charles Soria, Head of Oncology Therapeutic Area at Amgen, posted on LinkedIn

“The oncology dealmaking landscape is shifting! Pharma is moving beyond niche drugs to focus on ADCs, bispecifics and radioligand therapies. Low interest in narrow biomarker drugs, pharma is chasing pan-cancer blockbusters!”

Read Further.

Jean-Charles Soria: The oncology dealmaking landscape is shifting

cancer Jean-Charles Soria OncoDaily Oncology pan-cancer blockbusters
Special Coverage
Voices
Aug 13, 2025, 08:05
Alessandro Gronchi: International Sarcoma Community - Built on Science, Connection, and Trust
Science
Aug 13, 2025, 08:05
Chris Boshoff: Advancing Science to Improve Outcomes for Those Impacted by Muscle-Invasive Bladder Cancer
Voices
Aug 13, 2025, 08:04
From Supportive Care to Psychosocial Healing: UICC Members are Making a Difference
Blog Posts
Aug 13, 2025, 07:47
Ruben Mesa: Amazing Day Touring our World Class Cancer Teams of Advocate Health
Voices
Aug 13, 2025, 07:46
St. Jude Launches 150th “Science of Childhood Cancer” Lecture Series
Voices
Aug 13, 2025, 07:27
Calling on Congress to Preserve the Nation’s Investment in NIH - AACR
Voices
Aug 13, 2025, 07:27
Lung Cancer Care is Evolving Fast - SIOG
Insight
Aug 13, 2025, 07:15
Hadieh Eslampanah: Another Powerful Opportunity for MAHAK Institute
Science
Aug 13, 2025, 07:14
Emma M. Groarke: American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS
Voices
Aug 13, 2025, 07:14
Chair of CANCaRe Africa Working to Improve Care for Children with Cancer
Science
Aug 13, 2025, 07:01
Murali Janakiram: The Toxicity Profile of GPRC5D Bispecific Antibody Talquetamab
Societies
Aug 13, 2025, 06:35
NCI-funded Cancer Research Internship Positions Undergraduates for Success